Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation.

Insulin-like growth factor binding proteins (IGFBPs) comprise a family of secreted proteins that bind insulin-like growth factors-I and -II (IGF-I and -II) with high affinity and potentially modulate their biological effects. We have demonstrated previously that IGFBP-5, the most conserved of the six known IGFBPs, is expressed in muscle cells in the developing embryo and during the terminal differentiation of several myogenic cell lines. In this study we show that an IGF-I analog that binds minimally to IGFBPs potently enhances the differentiation of the stringently controlled inducible C2 myoblast (C2l) cell line and identify IGFBP-5 as the sole IGFBP secreted during C2l differentiation. We find that induction of IGFBP-5 mRNA and protein is coincident with the onset of myogenin gene expression and occurs secondary to the rapid activation of IGFBP-5 gene transcription. By transient gene transfer experiments we demonstrate that a 1004 base pair segment of the IGFBP-5 promoter is very active in directing expression of the reporter gene luciferase in C2l myoblasts. A promoter fragment containing only 156 nucleotides of 5'-flanking DNA retained more than 70% of maximal activity and mediated at least part of the differentiation-dependent rise in IGFBP-5 gene transcription. Within this active segment are several potential binding sites for muscle-enriched transcription factors. Our results show that induction of IGFBP-5 expression is an early event in the myogenic differentiation of the C2l cell line and suggest that one function of this IGFBP is to modulate IGF-induced differentiation. C2l cells are thus an excellent in vitro model for elucidating the developmental factors that control IGFBP-5 gene transcription and action in skeletal muscle.

[1]  Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. , 1991, Molecular and cellular biology.

[2]  S. Rosenthal,et al.  Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells. , 1995, Endocrinology.

[3]  J. Rosenbloom,et al.  Insulin-like growth factor-I regulates transcription of the elastin gene. , 1993, The Journal of biological chemistry.

[4]  J. Wallace,et al.  Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. , 1987, Biochemical and biophysical research communications.

[5]  N. Ling,et al.  Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells. , 1993, Endocrinology.

[6]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[7]  F. Gros,et al.  Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. , 1988, Differentiation; research in biological diversity.

[8]  M Ringwald,et al.  Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Andress,et al.  Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. , 1993, Biochemical and biophysical research communications.

[10]  D. Boettiger,et al.  Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation , 1987, Cell.

[11]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[12]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[13]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[14]  M. Rechler,et al.  Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. , 1994, Endocrinology.

[15]  J R Florini,et al.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. , 1991, The Journal of biological chemistry.

[16]  C. Larsson,et al.  Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. , 1994, The Journal of biological chemistry.

[17]  G. Norstedt,et al.  Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation. , 1992, Molecular endocrinology.

[18]  P. Rotwein,et al.  Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[20]  D. Clemmons,et al.  Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. , 1992, Endocrinology.

[21]  P. Rotwein,et al.  Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter. , 1995, DNA and cell biology.

[22]  P. Backeljauw,et al.  Synthesis and regulation of insulin-like growth factor binding protein-5 in FRTL-5 cells. , 1993, Endocrinology.

[23]  D. Baltimore,et al.  An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers , 1991, Cell.

[24]  A. Brasier,et al.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.

[25]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[26]  J. Sanes,et al.  Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis , 1992, Cell.